Cellular Differentiation Regulator BLIMP1 Induces Epstein-Barr Virus Lytic Reactivation in Epithelial and B Cells by Activating Transcription from both the R and Z Promoters

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Virology

• Publication date

  2014-11-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.02781-14PMID 25410866PMCID PMC4300755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of the latent-lytic switch in Epstein-Barr virus.

  2014cited by this paper
• Regulation of Epstein–Barr virus reactivation from latency

  2014cited by this paper
• A Balance between B Cell Receptor and Inhibitory Receptor Signaling Controls Plasma Cell Differentiation by Maintaining Optimal Ets1 Levels

  2014influential reference
• Comprehensive High-Throughput RNA Sequencing Analysis Reveals Contamination of Multiple Nasopharyngeal Carcinoma Cell Lines with HeLa Cell Genomes

  2014cited by this paper
• Switching of EBV cycles between latent and lytic states

  2014cited by this paper
• MCAF1 and Rta-Activated BZLF1 Transcription in Epstein-Barr Virus

  2014cited by this paper
• EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOID MALIGNANCIES: THE EXPANDING SPECTRUM OF HEMATOPOIETIC NEOPLASMS

  2013cited by this paper
• Inducible deletion of the Blimp-1 gene in adult epidermis causes granulocyte-dominated chronic skin inflammation in mice

  2013cited by this paper
• The B-Cell-Specific Transcription Factor and Master Regulator Pax5 Promotes Epstein-Barr Virus Latency by Negatively Regulating the Viral Immediate Early Protein BZLF1

  2013cited by this paper
• Contribution of Myocyte Enhancer Factor 2 Family Transcription Factors to BZLF1 Expression in Epstein-Barr Virus Reactivation from Latency

  2013cited by this paper
• Modulation of Ets‐1 Expression in B Lymphocytes is Dependent on the Antigen Receptor–mediated Activation Signals and Cell Cycle Status

  2013cited by this paper
• Transcription Factor Ets1, but Not the Closely Related Factor Ets2, Inhibits Antibody-Secreting Cell Differentiation

  2013cited by this paper
• Different Patterns of Epstein-Barr Virus Latency in Endemic Burkitt Lymphoma (BL) Lead to Distinct Variants within the BL-Associated Gene Expression Signature

  2012cited by this paper
• The B-Cell Specific Transcription Factor, Oct-2, Promotes Epstein-Barr Virus Latency by Inhibiting the Viral Immediate-Early Protein, BZLF1

  2012cited by this paper
• Viral Genome Methylation Differentially Affects the Ability of BZLF1 versus BRLF1 To Activate Epstein-Barr Virus Lytic Gene Expression and Viral Replication

  2012influential reference
• Lytic Epstein-Barr virus infection in epithelial cells but not in B-lymphocytes is dependent on Blimp1.

  2012influential reference
• Epstein-Barr virus infection

  2012cited by this paper
• Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated Lymphomas

  2012cited by this paper
• BLIMP1α, the master regulator of plasma cell differentiation is a tumor supressor gene in B cell lymphomas.

  2012cited by this paper
• Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.

  2011cited by this paper
• Positive Regulatory Domain I (PRDM1) and IRF8/PU.1 Counter-regulate MHC Class II Transactivator (CIITA) Expression during Dendritic Cell Maturation*

  2011cited by this paper
• CpG-Methylation Regulates a Class of Epstein-Barr Virus Promoters

  2010cited by this paper
• Blimp1: a conserved transcriptional repressor critical for differentiation of many tissues.

  2009cited by this paper
• The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer.

  2008cited by this paper
• Ets-1 Regulates Plasma Cell Differentiation by Interfering with the Activity of the Transcription Factor Blimp-1*

  2008cited by this paper
• Lytic cycle switches of oncogenic human gammaherpesviruses.

  2007cited by this paper
• X-Box-Binding Protein 1 Activates Lytic Epstein-Barr Virus Gene Expression in Combination with Protein Kinase D

  2007cited by this paper
• BLIMP1 regulates cell growth through repression of p53 transcription

  2007cited by this paper
• Epidermal terminal differentiation depends on B lymphocyte-induced maturation protein-1

  2007influential reference
• Plasma Cell-Specific Transcription Factor XBP-1s Binds to and Transactivates the Epstein-Barr Virus BZLF1 Promoter

  2007cited by this paper
• Loss of Pax5 promotes plasma cell differentiation.

  2006cited by this paper
• Functional Analysis of Promoter CPG-Methylation using a CpG-Free Luciferase Reporter Vector

  2006cited by this paper
• Terminal Differentiation into Plasma Cells Initiates the Replicative Cycle of Epstein-Barr Virus In Vivo

  2005cited by this paper
• Effects of n-Butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation

  2005cited by this paper
• Epstein-Barr Virus Provides a New Paradigm: A Requirement for the Immediate Inhibition of Apoptosis

  2005cited by this paper
• The Influence of CCL3L1 Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility

  2005cited by this paper
• Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex

  2005influential reference
• The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome

  2004cited by this paper
• B Lymphocyte-Induced Maturation Protein (Blimp)-1, IFN Regulatory Factor (IRF)-1, and IRF-2 Can Bind to the Same Regulatory Sites1

  2004cited by this paper
• PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing

  2004cited by this paper
• Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells.

  2003cited by this paper
• Identification of a Functionally Impaired Positive Regulatory Domain I Binding Factor 1 Transcription Repressor in Myeloma Cell Lines1

  2003influential reference
• Synergistic autoactivation of the Epstein-Barr virus immediate-early BRLF1 promoter by Rta and Zta.

  2003cited by this paper
• Blimp-1-Dependent Repression of Pax-5 Is Required for Differentiation of B Cells to Immunoglobulin M-Secreting Plasma Cells

  2002cited by this paper
• Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program.

  2002cited by this paper
• Epstein–Barr virus–associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2

  2002cited by this paper
• Epstein-Barr Virus Immediate-Early Protein BZLF1 Is SUMO-1 Modified and Disrupts Promyelocytic Leukemia Bodies

  2001cited by this paper
• Autostimulation of the Epstein-Barr Virus BRLF1 Promoter Is Mediated through Consensus Sp1 and Sp3 Binding Sites

  2001cited by this paper
• Positive Regulatory Domain I Binding Factor 1 Silences Class II Transactivator Expression in Multiple Myeloma Cells*

  2001influential reference
• Identification of a Novel Element Involved in Regulation of the Lytic Switch BZLF1 Gene Promoter of Epstein-Barr Virus

  2001cited by this paper
• The Epstein–Barr virus lytic program is controlled by the co‐operative functions of two transactivators

  2000cited by this paper
• Epstein-Barr virus infection.

  2000cited by this paper
• Epstein-Barr Virus Immediate-Early Proteins BZLF1 and BRLF1 Activate the ATF2 Transcription Factor by Increasing the Levels of Phosphorylated p38 and c-Jun N-Terminal Kinases

  2000cited by this paper
• Transcriptional Repression by Blimp-1 (PRDI-BF1) Involves Recruitment of Histone Deacetylase

  2000cited by this paper
• Epstein-barr virus-induced posttransplant lymphoproliferative disorders

  1999cited by this paper
• A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development.

  1999cited by this paper
• A Novel Element and a TEF-2-like Element Activate the Major Histocompatibility Complex Class II Transactivator in B-lymphocytes*

  1999cited by this paper
• Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.

  1999cited by this paper
• PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins.

  1999cited by this paper
• Role of the Epstein-Barr Virus Rta Protein in Activation of Distinct Classes of Viral Lytic Cycle Genes

  1999cited by this paper
• The PR Domain of the Rb-binding Zinc Finger Protein RIZ1 Is a Protein Binding Interface and Is Related to the SET Domain Functioning in Chromatin-mediated Gene Expression*

  1998cited by this paper
• The Epstein-Barr Virus Rta Protein Activates Lytic Cycle Genes and Can Disrupt Latency in B Lymphocytes

  1998cited by this paper
• Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene.

  1997cited by this paper
• Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation.

  1997cited by this paper
• Establishment and characterization of human gastric carcinoma cell lines

  1997influential reference
• Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.

  1996cited by this paper
• A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator

  1996cited by this paper
• Epstein-Barr virus and its replication

  1996cited by this paper
• Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells.

  1994cited by this paper
• Epstein-Barr virus-associated gastric adenocarcinoma.

  1992cited by this paper
• Only two of the five zinc fingers of the eukaryotic transcriptional repressor PRDI-BF1 are required for sequence-specific DNA binding

  1992cited by this paper
• Induction of Epstein-Barr virus lytic cycle by tumor-promoting and non-tumor-promoting phorbol esters requires active protein kinase C

  1991cited by this paper
• Identification and characterization of a novel repressor of beta-interferon gene expression.

  1991cited by this paper
• Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia

  1991cited by this paper
• Pathways of activation of the Epstein-Barr virus productive cycle

  1991cited by this paper
• Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1

  1990cited by this paper
• An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators

  1990cited by this paper
• Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1

  1990cited by this paper
• Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

  1989cited by this paper
• The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.

  1988cited by this paper
• Early signals for keratinocyte differentiation: role of Ca2+-mediated inositol lipid metabolism in normal and neoplastic epidermal cells.

  1988cited by this paper
• A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen

  1988cited by this paper
• Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency

  1987cited by this paper
• trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment

  1986cited by this paper
• Both Epstein‐Barr virus (EBV)‐encoded trans‐acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.

  1986cited by this paper
• Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.

  1985cited by this paper
• The tumor promoter, 12-O-tetradecanoylphorbol-13-acetate accelerates keratinocyte differentiation and stimulates growth of an unidentified cell type in cultured human epidermis.

  1982cited by this paper
• Differentiation of normal and cultured preneoplastic tracheal epithelial cells in rats: importance of epithelial mesenchymal interactions.

  1980cited by this paper
• Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells

  1980cited by this paper
• Tumor initiators and promoters in the induction of Epstein-Barr virus.

  1979cited by this paper
• Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line.

  1976cited by this paper
• Nasopharyngeal carcinoma. X. Presence of Epstein‐Barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya

  1975cited by this paper
• Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

  1970cited by this paper
• Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.

  1968cited by this paper
• Nasopharyngeal Carcinoma

  1966cited by this paper
• VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

  1964cited by this paper

• The EBNA3 Proteins.

  2026cites this paper
• Lysine-specific histone demethylase complex restricts Epstein–Barr virus lytic reactivation

  2025cites this paper
• Reconstructing EBV reactivation and DNA damage response kinetics in morphologic pseudotime

  2025cites this paper
• E2F1 suppresses Epstein-Barr virus lytic reactivation through cellular and viral transcriptional networks

  2025cites this paper
• Advances in Epstein–Barr Virus Detection: From Traditional Methods to Modern Technologies

  2025cites this paper
• Chromatin Control of EBV Infection and Latency.

  2025cites this paper
• IRF6 controls Epstein-Barr virus (EBV) lytic reactivation and differentiation in EBV-infected epithelial cells

  2025cites this paper
• OCT3-4 and SOX2 in Oral Lichen Planus Compared to Oral Leukoplakia: An Immunohistochemical Study

  2025cites this paper
• Epstein–Barr virus pathogenesis and emerging control strategies

  2025cites this paper
• Multiple sclerosis and infection: history, EBV, and the search for mechanism

  2025cites this paper
• The Histone Demethylase LSD1/ZNF217/CoREST Complex is a Major Restriction Factor of Epstein-Barr Virus Lytic Reactivation

  2025cites this paper
• Altered EBV specific immune control in multiple sclerosis.

  2024cites this paper
• Identifying the key regulators orchestrating Epstein-Barr virus reactivation

  2024cites this paper
• Epstein-Barr virus reactivation induces divergent abortive, reprogrammed, and host shutoff states by lytic progression

  2024cites this paper
• Functional Targets for Epstein-Barr Virus BART MicroRNAs in B Cell Lymphomas

  2024cites this paper
• The unappreciated role of developing B cells in chronic gammaherpesvirus infections

  2024cites this paper
• Epstein-Barr virus replication within differentiated epithelia requires pRb sequestration of activator E2F transcription factors

  2024cites this paper
• Epstein-Barr virus reactivation induces divergent abortive, reprogrammed, and host shutoff states by lytic progression

  2024cites this paper
• MicroRNA-focused CRISPR/Cas9 screen identifies miR-142 as a key regulator of Epstein-Barr virus reactivation

  2024cites this paper
• Hemin treatment drives viral reactivation and plasma cell differentiation of EBV latently infected B cells

  2023cites this paper
• A distinct isoform of lymphoid enhancer binding factor 1 (LEF1) epigenetically restricts EBV reactivation to maintain viral latency

  2023cites this paper
• Viral and host factors drive a type 1 Epstein–Barr virus spontaneous lytic phenotype

  2023cites this paper
• The Dual Functions of Andrographolide in the Epstein–Barr Virus-Positive Head-and-Neck Cancer Cells: The Inhibition of Lytic Reactivation of the Epstein–Barr Virus and the Induction of Cell Death

  2023cites this paper
• Differences in the Tumor Microenvironment of EBV-Associated Gastric Cancers Revealed Using Single-Cell Transcriptome Analysis

  2023cites this paper
• Retinoblastoma Protein Is Required for Epstein-Barr Virus Replication in Differentiated Epithelia

  2023cites this paper
• Reactivation of Epstein-Barr Virus from Latency Involves Increased RNA Polymerase Activity at CTCF Binding Sites on the Viral Genome

  2023influential citation
• Co-Infection of the Epstein–Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus

  2022cites this paper
• Epstein–Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 Patients

  2022cites this paper
• A comprehensive single cell data analysis of lymphoblastoid cells reveals the role of super‐enhancers in maintaining EBV latency

  2022cites this paper
• A Polymorphism in the Epstein-Barr Virus EBER2 Noncoding RNA Drives In Vivo Expansion of Latently Infected B Cells

  2022cites this paper
• Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells

  2022cites this paper
• EBV Association with Lymphomas and Carcinomas in the Oral Compartment

  2022cites this paper
• A comprehensive single cell data analysis of in lymphoblastoid cells reveals the role of Super-enhancers in maintaining EBV latency

  2022cites this paper
• Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes

  2022cites this paper
• Natural killer cell responses to human oncogenic γ-herpesvirus infections.

  2022cites this paper
• The Role of Coinfections in the EBV–Host Broken Equilibrium

  2021cites this paper
• Regulation of the Macroautophagic Machinery, Cellular Differentiation, and Immune Responses by Human Oncogenic γ-Herpesviruses

  2021cites this paper
• Clinical Manifestations and Epigenetic Regulation of Oral Herpesvirus Infections

  2021cites this paper
• B Cell Receptor-Responsive miR-141 Enhances Epstein-Barr Virus Lytic Cycle via FOXO3 Inhibition

  2021cites this paper
• Long non-coding RNAs in Epstein–Barr virus-related cancer

  2021cites this paper
• Roles of Lytic Viral Replication and Co-Infections in the Oncogenesis and Immune Control of the Epstein–Barr Virus

  2021influential citation
• Epigenetic control of the Epstein-Barr lifecycle.

  2021cites this paper
• Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation

  2021cites this paper
• ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells

  2021influential citation
• Reactivation of Epstein Barr Virus from Latency Involves Increased RNA Polymerase Activity at CTCF Binding Sites on The Viral Genome

  2021cites this paper
• Stress-Induced Epstein-Barr Virus Reactivation

  2021cites this paper
• MicroRNA and Other Non-Coding RNAs in Epstein–Barr Virus-Associated Cancers

  2021cites this paper
• Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells

  2021influential citation
• Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals

  2020cites this paper
• MYC Controls the Epstein-Barr Virus Lytic Switch.

  2020influential citation
• Herpesvirus latency.

  2020cites this paper
• Reactivation of Epstein-Barr Virus by HIF-1α Requires p53

  2020cites this paper
• Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell Cycle

  2019cites this paper
• Pathogenesis of Human Gammaherpesviruses: Recent Advances

  2019cites this paper
• Smoking can increase nasopharyngeal carcinoma risk by repeatedly reactivating Epstein‐Barr Virus: An analysis of a prospective study in southern China

  2019cites this paper
• Evolutionary effects of the AID/APOBEC family of mutagenic enzymes on human gamma-herpesviruses

  2019cites this paper
• B Cell Receptor-Responsive miR-141 and viral miR-BART9 promote Epstein-Barr Virus Reactivation Through FOXO3 Inhibition

  2019cites this paper
• Epstein-Barr virus microRNAs regulate B cell receptor signal transduction and lytic reactivation

  2019cites this paper
• IL-10 knockdown with siRNA enhances the efficacy of Doxorubicin chemotherapy in EBV-positive tumors by inducing lytic cycle via PI3K/p38 MAPK/NF-kB pathway.

  2019cites this paper
• Latency and lytic replication in Epstein–Barr virus-associated oncogenesis

  2019cites this paper
• IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells.

  2019cites this paper
• Epstein–Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ΔNp63α in Undifferentiated Nasopharyngeal Carcinoma

  2018cites this paper
• Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes

  2018cites this paper
• Epigenetic crossroads of the Epstein-Barr virus B-cell relationship.

  2018cites this paper
• Epstein-Barr virus in the pathogenesis of oral cancers.

  2018cites this paper
• The Dynamic Roles of TGF-β Signalling in EBV-Associated Cancers

  2018cites this paper
• Precision Molecular Pathology of Hodgkin Lymphoma

  2018cites this paper
• CRISPR – Cas 9 Genetic Analysis of Virus – Host Interactions

  2018cites this paper
• Contribution of tumour cell signalling and the microenvironment to the pathogenesis of EBV-associated B cell lymphoma and

  2018cites this paper
• Role of EBV in Classical Hodgkin Lymphoma

  2018cites this paper
• Interferon regulatory factor 8 regulates caspase-1 expression to facilitate Epstein-Barr virus reactivation in response to B cell receptor stimulation and chemical induction

  2018cites this paper
• CRISPR–Cas9 Genetic Analysis of Virus–Host Interactions

  2018cites this paper
• Epstein-Barr virus diagnostic and therapeutic opportunities in nasopharyngeal carcinoma

  2018cites this paper
• Roles of Non-coding RNAs During Herpesvirus Infection.

  2018cites this paper
• Virus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling

  2017cites this paper
• Epigenetic Consequences of Epstein–Barr Virus Infection

  2017cites this paper
• CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors.

  2017cites this paper
• EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency

  2017cites this paper
• Murine gammaherpesvirus M2 antigen modulates splenic B cell activation and terminal differentiation in vivo

  2017cites this paper
• Selective expression of the transcription elongation factor ELL3 in B cells prior to ELL2 drives proliferation and survival

  2017cites this paper
• S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells

  2017cites this paper
• Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus’s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter

  2017cites this paper
• Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.

  2017cites this paper
• Agents and Approaches for Lytic Induction Therapy of Epstein-Barr Virus Associated Malignancies : Virus-targeted therapy in EBV linked carcinoma

  2016cites this paper
• An Epstein-Barr Virus-Encoded Protein Complex Requires an Origin of Lytic Replication In Cis to Mediate Late Gene Transcription

  2016cites this paper
• Epstein‐Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin

  2016cites this paper
• Epstein–Barr Virus: Diseases Linked to Infection and Transformation

  2016influential citation
• Epstein-Barr Virus Lytic Cycle Reactivation.

  2015cites this paper
• OBTENÇÃO DE ANTICORPOS MONOCLONAIS HUMANOS ANTITETÂNICOS

  2015cites this paper
• The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma

  2015cites this paper
• 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch

  2015cites this paper
• Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells

  2015influential citation
• Rôle de l'interaction entre la protéine virale EBNA1 et le facteur cellulaire RCC1 dans la persistance du génome du virus d'Epstein-Barr

  2015cites this paper
• The Epigenetic Life Cycle of Epstein-Barr Virus.

  2015cites this paper
• Epstein Barr Virus Volume 2

  2015cites this paper
• Contribution of the Epstein-Barr Virus to the Pathogenesis of Hodgkin Lymphoma.

  2015cites this paper
• Epstein–Barr Virus

  2014cites this paper
• Hypoxia-inducible factor-1 α plays roles in Epstein-Barr virus ’ s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF 1 gene promoter

  year unknowncites this paper